1. Home
  2. RNA vs PRIM Comparison

RNA vs PRIM Comparison

Compare RNA & PRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • PRIM
  • Stock Information
  • Founded
  • RNA 2012
  • PRIM 1960
  • Country
  • RNA United States
  • PRIM United States
  • Employees
  • RNA N/A
  • PRIM N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • PRIM Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • RNA Health Care
  • PRIM Industrials
  • Exchange
  • RNA Nasdaq
  • PRIM Nasdaq
  • Market Cap
  • RNA 3.6B
  • PRIM 4.2B
  • IPO Year
  • RNA 2020
  • PRIM N/A
  • Fundamental
  • Price
  • RNA $34.04
  • PRIM $87.44
  • Analyst Decision
  • RNA Strong Buy
  • PRIM Strong Buy
  • Analyst Count
  • RNA 14
  • PRIM 10
  • Target Price
  • RNA $67.71
  • PRIM $88.60
  • AVG Volume (30 Days)
  • RNA 1.9M
  • PRIM 843.2K
  • Earning Date
  • RNA 08-08-2025
  • PRIM 08-04-2025
  • Dividend Yield
  • RNA N/A
  • PRIM 0.37%
  • EPS Growth
  • RNA N/A
  • PRIM 41.89
  • EPS
  • RNA N/A
  • PRIM 3.77
  • Revenue
  • RNA $8,927,000.00
  • PRIM $6,602,243,000.00
  • Revenue This Year
  • RNA N/A
  • PRIM $8.74
  • Revenue Next Year
  • RNA $156.80
  • PRIM $5.56
  • P/E Ratio
  • RNA N/A
  • PRIM $23.23
  • Revenue Growth
  • RNA N/A
  • PRIM 12.45
  • 52 Week Low
  • RNA $21.51
  • PRIM $45.92
  • 52 Week High
  • RNA $56.00
  • PRIM $90.86
  • Technical
  • Relative Strength Index (RSI)
  • RNA 63.10
  • PRIM 68.17
  • Support Level
  • RNA $31.62
  • PRIM $83.72
  • Resistance Level
  • RNA $35.29
  • PRIM $88.24
  • Average True Range (ATR)
  • RNA 1.74
  • PRIM 2.43
  • MACD
  • RNA 0.53
  • PRIM 0.20
  • Stochastic Oscillator
  • RNA 83.48
  • PRIM 92.86

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

About PRIM Primoris Services Corporation

Primoris Services Corp is a provider of infrastructure services operating mainly in the United States and Canada. It provides a wide range of construction services, maintenance, replacement, fabrication and engineering services to a diversified base of customers. The reportable segments are the Utilities segment and the Energy segment. The Utilities segment operates in a range of services, including the installation and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communication systems. The Energy segment operates in a range of services that include engineering, procurement, and construction, retrofits, highway and bridge construction, demolition, site work, outages, pipeline construction and maintenance, and others.

Share on Social Networks: